261 related articles for article (PubMed ID: 33136178)
1. Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.
Zaborowski MP; Stefens-Stawna P; Osztynowicz K; Piorunek T; Batura-Gabryel H; Dyzmann-Sroka A; Kozubski W; Nowak-Markwitz E; Michalak S
Cancer Immunol Immunother; 2021 May; 70(5):1277-1289. PubMed ID: 33136178
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune response in lung cancer patients with neurological paraneoplastic syndromes.
Michalak S; Piorunek T; Zaborowski M; Rybacka-Mossakowska J; Stefens-Stawna P; Kalinowska-Łyszczarz A; Kozubski W; Batura-Gabryel H
Neurol Neurochir Pol; 2019; 53(3):217-226. PubMed ID: 31187476
[TBL] [Abstract][Full Text] [Related]
3. A single center retrospective study of paraneoplastic neurological syndromes with positive onconeural antibodies.
Fu P; He L; Tang N; Nie Q; Li Z
J Clin Neurosci; 2021 Jul; 89():336-342. PubMed ID: 34119290
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
Raspotnig M; Vedeler C; Storstein A
J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
[TBL] [Abstract][Full Text] [Related]
5. A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling.
Briones JC; Espulgar WV; Koyama S; Yoshikawa H; Park J; Naito Y; Kumanogoh A; Tamiya E; Takamatsu H; Saito M
Theranostics; 2020; 10(1):123-132. PubMed ID: 31903110
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses in paraneoplastic neurological syndromes.
Zaborowski MP; Michalak S
Clin Dev Immunol; 2013; 2013():630602. PubMed ID: 24575143
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
9. Neurological paraneoplastic syndromes in lung cancer patients.
Stefens-Stawna P; Piorunek T; Gabryel-Batura H; Kozubski W; Michalak S
Adv Exp Med Biol; 2013; 756():333-9. PubMed ID: 22836651
[TBL] [Abstract][Full Text] [Related]
10. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
12. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers.
Ma J; Wang A; Jiang W; Ma L; Lin Y
Thorac Cancer; 2021 Aug; 12(16):2265-2270. PubMed ID: 34242487
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurological syndromes: a review.
Toothaker TB; Rubin M
Neurologist; 2009 Jan; 15(1):21-33. PubMed ID: 19131854
[TBL] [Abstract][Full Text] [Related]
18. Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes.
Xie D; McElhaney JE
Mech Ageing Dev; 2007; 128(5-6):392-400. PubMed ID: 17570460
[TBL] [Abstract][Full Text] [Related]
19. Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials.
Shafer-Weaver K; Rosenberg S; Strobl S; Gregory Alvord W; Baseler M; Malyguine A
J Immunother; 2006; 29(3):328-35. PubMed ID: 16699376
[TBL] [Abstract][Full Text] [Related]
20. Leucine Zipper 4 Autoantibody: A Novel Germ Cell Tumor and Paraneoplastic Biomarker.
Dubey D; Kryzer T; Guo Y; Clarkson B; Cheville JC; Costello BA; Leibovich BC; Algeciras-Schimnich A; Lucchinnetti C; Hammami MB; Knight AM; Howe C; Lennon VA; McKeon A; Pittock SJ
Ann Neurol; 2021 May; 89(5):1001-1010. PubMed ID: 33583072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
